The Wall Street Journal reports, “US Sen. Charles Grassley expressed concern that a list of consultants provided to him by Medtronic Inc. doesn’t include a doctor accused of falsifying data in a favorable study of the company’s Infuse bone-graft product.” The list “of 22 consultants provided to Sen. Grassley as part of a request for information he made in October” does not include surgeon Timothy Kuklo, who Medtronic “has said…was a consultant.” In a May 18 letter to Medtronic Chief Executive Bill Hawkins, Sen. Grassley wrote that he is “concerned that Medtronic did not include Dr. Timothy Kuklo in response to [his] written request.” The New York Times and the AP also report the story.
From the American Association for Justice news release.
